Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type i collagen

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Seandel, M.
  • Noack-Kunnmann, K.
  • Zhu, D.
  • Aimes, R. T.
  • Quigley, James

publication date

  • April 2001

journal

  • Blood  Journal

abstract

  • The contribution of specific type I collagen remodeling in angiogenesis was studied in vivo using a quantitative chick embryo assay that measures new blood vessel growth into well-defined fibrillar collagen implants. In response to a combination of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), a strong angiogenic response was observed, coincident with invasion into the collagen implants of activated fibroblasts, monocytes, heterophils, and endothelial cells. The angiogenic effect was highly dependent on matrix metalloproteinase (MMP) activity, because new vessel growth was inhibited by both a synthetic MMP inhibitor, BB3103, and a natural MMP inhibitor, TIMP-1. Multiple MMPs were detected in the angiogenic tissue including MMP-2, MMP-13, MMP-16, and a recently cloned MMP-9-like gelatinase. Using this assay system, wild-type collagen was compared to a unique collagenase-resistant collagen (r/r), with regard to the ability of the respective collagen implants to support cell invasion and angiogenesis. It was found that collagenase-resistant collagen constitutes a defective substratum for angiogenesis. In implants made with r/r collagen there was a substantial reduction in the number of endothelial cells and newly formed vessels. The presence of the r/r collagen, however, did not reduce the entry into the implants of other cell types, that is, activated fibroblasts and leukocytes. These results indicate that fibrillar collagen cleavage at collagenase-specific sites is a rate-limiting event in growth factor-stimulated angiogenesis in vivo.

subject areas

  • Allantois
  • Animals
  • Cells, Cultured
  • Chick Embryo
  • Chorion
  • Collagen
  • Collagenases
  • Endothelial Growth Factors
  • Endothelium, Vascular
  • Extracellular Matrix
  • Fibroblast Growth Factor 2
  • Fibroblasts
  • Hydroxamic Acids
  • Leukocytes
  • Lymphokines
  • Metalloendopeptidases
  • Neovascularization, Physiologic
  • Prostheses and Implants
  • Protease Inhibitors
  • Stromal Cells
  • Surgical Mesh
  • Tissue Inhibitor of Metalloproteinase-1
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood.V97.8.2323

PubMed ID

  • 11290594
scroll to property group menus

Additional Document Info

start page

  • 2323

end page

  • 2332

volume

  • 97

issue

  • 8

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support